High-Resolution Analysis of Peptides and Proteins - New AdvanceBio SEC 120 Å 1.9 μm columns

Significance of the Topic

Size exclusion chromatography is a key reference technique for characterizing protein aggregates, which are critical quality attributes in biotherapeutics. Accurate analysis of peptides and small proteins is essential to ensure product safety, efficacy, and regulatory compliance.

Objectives and Study Overview

The study presents new AdvanceBio SEC 120 Å 1.9 μm columns designed for ultra high performance and minimal secondary interactions. The goals were to evaluate their separation efficiency for peptides and small proteins, compare performance against competitor columns, and assess long term stability and reproducibility.

Methodology and Instrumentation

• Stationary phase: monodisperse silica particles of 1.9 μm with 120 Å pores and hydrophilic bonding chemistry to minimize nonspecific binding
• Instrumentation: Agilent 1260 Infinity II Bio-inert LC system with OpenLab CDS software
• Columns: 4.6 x 300 mm (also available in 150 mm and guard formats)
• Eluents: arginine/acetic acid/acetonitrile (65/15/20 v/v/v) and phosphate buffer (100–150 mM, pH 6.8–7.0)
• Flow rate: 0.30–0.35 mL/min; injection volume: 2 μL; detection by UV at 220 or 276 nm; temperature: 25 °C

Key Results and Discussion

• Peptide and protein separation achieved high resolution with Rs up to 4.03 for insulin aggregates, outperforming competitor columns (Rs 2.19 and 1.62)
• Model compounds (ovalbumin, myoglobin, aprotinin, neurotensin, uridine) showed sharp peaks and clear baseline separation across 0.5–15 min retention range
• Stressed insulin samples delivered 97.7% monomer recovery and distinct aggregate and fragment peaks with minimal tailing
• Human growth hormone analysis demonstrated superior protein recovery and peak shape, indicating reduced secondary interactions
• Column lifetime testing over 550 injections showed less than 10% drop in plate count, confirming exceptional mechanical stability
• Batch-to-batch reproducibility studies revealed consistent retention times and response profiles across multiple production lots

Benefits and Practical Applications

• Rapid, high-resolution analysis supports efficient quality control workflows in biopharmaceutical development
• Inert surface chemistry reduces variability and improves accuracy in aggregate quantitation
• Extended column lifetime and robust performance lower operational costs and downtime
• Validated method kits facilitate regulatory compliance and streamline method validation processes

Future Trends and Potential Applications

Emerging directions include coupling SEC with mass spectrometry for detailed structural analysis, adopting microfluidic SEC formats for high-throughput screening, and integrating artificial intelligence for automated method optimization and predictive maintenance.

Conclusion

AdvanceBio SEC 120 Å 1.9 μm columns offer superior resolution, minimal secondary interactions, and proven durability for peptide and small protein analysis. Their performance and reproducibility make them a valuable tool for research and quality control in the biopharmaceutical industry.